Clinicore

General information

After years in the clinical lab space, Kris Franklin inspired by the desire to create something meaningful and useful to the clinical lab space began looking for ways to simplify sample collection and open up a greater array of blood diagnostics to the average reference lab. Dissatisfied by the clinical utility of urine toxicology and the difficulty of venous blood collection, Kris Franklin set out to find a way to simplify the collection process and expand diagnostic testing. In November of 2014, Kris Franklin met with Dr. Hooper over coffee to understand the fundamentals of small volume blood and how he applied a simplified collection technique to assist transplant patients taking immunosuppressants. From that coffee shop meeting the concept was born. The concept was simple utilize high end tandem mass spectrometry to reduce the amount of blood needed, so blood collection could be performed by the patient.

Meetings with lab groups and different teams produced little opportunity to begin the work on a critical piece of technology. In 2015 a relationship was struck with a company and using Shimadzu tandem mass spectrometers the first prototype of a small volume blood application was created. Before product launch could become reality, the equipment was liquidated, but the dream and passion never subsided. As a consultant, Kris Franklin would work in other labs he had established and borrow time on their equipment to push the technology farther and create new ways to create better science. Unique sample prep technology combined with advanced tandem mass spectrometry experience led to scientific leaps forward in what was possible.

In July of 2017 Kris Franklin took on 2 partners. One was technology savvy investor who saw the value in the technology that was created and the unique opportunity it provided. The other was a brilliant pathologist who also recognized the value of the technology. From those early meetings in 2017 Clinicore was formed. A company forged out of tireless persistence and a relentless pursuit of scientific perfection. Clinicore opened with a 12-million-dollar valuation and a mandate to utilize science to improve the quality of patient care. With resources in hand, Kris Franklin and his team focus on bringing novel diagnostic testing to the clinical arena.